State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
NCT06154278 Phase 2
Recruiting
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis...
Condition
Chronic Hepatitis B
Enrollment
10 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06447025 Phase 2
Recruiting
An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
Condition
Friedreich Ataxia
Enrollment
85 pts
Location
United States
Sponsor
Larimar Therapeutics, Inc.
NCT07162038 Phase 1
Recruiting
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Tra...
Condition
Hematologic Malignancies
Enrollment
155 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07423598 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynam...
Condition
Healthy Participants
Enrollment
40 pts
Location
United States
Sponsor
AstraZeneca
NCT06364644 N/A
Recruiting
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for ...
Condition
Type2diabetes
Enrollment
210 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06163534 N/A
Recruiting
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Tempus AI
NCT05805709 N/A
Recruiting
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI P...
Condition
Acute Kidney Injury
Enrollment
2,145 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06310239 N/A
Recruiting
Microbiome Population Adaptation Study
Condition
Amputation With Osseointegration
Enrollment
50 pts
Location
United States
Sponsor
Walter Reed National Military
NCT06487481 Phase 1
Recruiting
Study of Preoperative Radiation Therapy in Participants With Resectable Recurren...
Condition
Adrenocortical Carcinoma (ACC)
Enrollment
32 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03813407 Phase 3
Recruiting
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients ...
Condition
Hyperkalaemia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT07220122 EARLY_Phase 1
Recruiting
Impact of Exogenous Ketones on Breathing in Healthy Volunteers
Condition
Healthy Volunteer
Enrollment
20 pts
Location
United States
Sponsor
Johns Hopkins University
NCT04862663 Phase 3
Recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Ca...
Condition
Locally Advanced (Inoperable) or Metastatic Breast Cancer
Enrollment
895 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06795022 Phase 1, Phase 2
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metast...
Condition
Hepatocellular Carcinoma
Enrollment
304 pts
Location
United States, China, Hong Kong
Sponsor
AstraZeneca
NCT04998877 N/A
Recruiting
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects an...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
60 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05407636 Phase 3
Recruiting
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Condition
AMD
Enrollment
660 pts
Location
United States, Canada, France
Sponsor
AbbVie
NCT05712200 Phase 3
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients Wi...
Condition
Atrial Fibrillation (AF)
Enrollment
1,900 pts
Location
United States, Argentina, Brazil
Sponsor
Anthos Therapeutics, Inc.
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06850922 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ...
Condition
Diabetic Macular Edema
Enrollment
546 pts
Location
United States, China, Puerto Rico
Sponsor
Genentech, Inc.
NCT02359253 N/A
Recruiting
Robot Aided Rehabilitation - Intervention
Condition
Stroke
Enrollment
72 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT05926765 Phase 2
Recruiting
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late X...
Condition
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Enrollment
276 pts
Location
United States, Canada, United Kingdom
Sponsor
MeiraGTx, LLC
NCT00923507 N/A
Recruiting
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocy...
Condition
Waldenstrom Macroglobulinemia
Enrollment
1,000 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT05036707 Phase 1, Phase 2
Recruiting
Human Immune Response to Ixodes Scapularis Tick Bites
Condition
Tick-borne Diseases
Enrollment
60 pts
Location
United States
Sponsor
National Institute of Allergy
NCT02257892 N/A
Recruiting
Novel Genetic Disorders of the Immune System
Condition
PI3KCD
Enrollment
500 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06449677 Phase 3
Recruiting
Bionic Pancreas in CFRD
Condition
Cystic Fibrosis-related Diabetes
Enrollment
150 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT05083481 Phase 1, Phase 2
Recruiting
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembro...
Condition
Advanced Solid Tumors
Enrollment
366 pts
Location
United States, China, France
Sponsor
Astellas Pharma Global Develop